High materiality8/10
Regeneron assumed with Buy from Neutral at UBS
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises REGN target to $978; posted price $778.36; Buy stance.
- UBS PT to $978; price $778.36.
Key facts
- 01
Target: $978
- 02
Posted price: $778.36
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.